The expression of RUNX1, ZNF519, PLAGL2, RBPJ, HOXA10, TEAD1, ZFP161, ARNT, MTF1 and HBP1 had no significant impact on RFS of HCC patients (Figure S1B). This evidence concerns the gene PLAGL2 and hepatocellular carcinoma.